MedTrace Logo

BIOSURE™ HEALICOIL™ PK Bone In-growth Study

NCT02382341 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 12

Last updated 2020-09-07

No results posted yet for this study

Summary

The study seeks to document the bone in-growth into the BIOSURE™ HEALICOIL PK screw as measured by CT scans. Patients' improvement in pain and function will also be followed through various outcome measures.

Conditions

  • Deficiency of Anterior Cruciate Ligament

Interventions

DEVICE

BIOSURE™ HEALICOIL™ PK Interference Screw

Subjects will receive the appropriate sized BIOSURE™ HEALICOIL™ PK Interference Screw

Sponsors & Collaborators

  • Smith & Nephew, Inc.

    lead INDUSTRY

Principal Investigators

  • Martin Lind, MD, PhD · Aarhus University Hospital

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-12
Primary Completion
2017-01-04
Completion
2017-01-04

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02382341 on ClinicalTrials.gov